A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo
Vascular Pharmacology · 2024
DOI: 10.1016/j.vph.2024.107369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Pharmacology, 2024. Verfasst von Dinesh Yadav und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Immunopathology Research Laboratory, Division of Neuromuscular Disease, Department of Neurology, University of Alabama at Birmingham, B…. Hauptthemen laut MEDLINE: Endothelial Cells, Integrases, Tamoxifen, von Willebrand Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: University of Alabama at Birmingham.
Abstract (Originalsprache)
Mouse models are invaluable to understanding fundamental mechanisms in vascular biology during development, in health and different disease states. Several constitutive or inducible models that selectively knockout or knock in genes in vascular endothelial cells exist; however, functional and phenotypic differences exist between microvascular and macrovascular endothelial cells in different organs. In order to study microvascular endothelial cell-specific biological processes, we developed a Tamoxifen-inducible von Willebrand Factor (vWF) Cre recombinase mouse in the SJL background. The transgene consists of the human vWF promoter with the microvascular endothelial cell-selective 734 base pair sequence to drive Cre recombinase fused to a mutant estrogen ligand-binding domain [ERT2] that requires Tamoxifen for activity (CreERT2) followed by a polyadenylation (polyA) signal. We initially observed Tamoxifen-inducible restricted bone marrow megakaryocyte and sciatic nerve microvascular endothelial cell Cre recombinase expression in offspring of a mixed strain hemizygous C57BL/6-SJL founder mouse bred with mT/mG mice, with >90% bone marrow megakaryocyte expression efficiency. Founder mouse offspring were backcrossed to the SJL background by speed congenics, and intercrossed for >10 generations to develop hemizygous Tamoxifen-inducible vWF Cre recombinase (vWF-iCre/+) SJL mice with stable transgene insertion in chromosome 1. Microvascular endothelial cell-specific Cre recombinase expression occurred in the sciatic nerves, brains, spleens, kidneys and gastrocnemius muscles of adult vWF-iCre/+ SJL mice bred with Ai14 mice, with retained low level bone marrow and splenic megakaryocyte expression. This novel mouse strain would support hypothesis-driven mechanistic studies to decipher the role(s) of specific genes transcribed by microvascular endothelial cells during development, as well as in physiologic and pathophysiologic states in an organ- and time-dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuromuscular Immunopathology Research Laboratory, Division of Neuromuscular Disease, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
- Transgenic Animal Model Core, University of Michigan, Ann Arbor, MI, USA.
- Neuromuscular Immunopathology Research Laboratory, Division of Neuromuscular Disease, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: ubogu@uab.edu.
Förderung
- University of Alabama at Birmingham
Zitieren
APA
Yadav, D., Conner, J. A., Wang, Y., Saunders, T. L., & Ubogu, E. E. (2024). A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2024.107369
Vancouver
Yadav D, Conner JA, Wang Y, Saunders TL, Ubogu EE. A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo. Vascular Pharmacology. 2024. doi:10.1016/j.vph.2024.107369
BibTeX
@article{Yadav2024,
author = {Yadav, Dinesh and Conner, Jeremy A and Wang, Yimin and Saunders, Thomas L and Ubogu, Eroboghene E},
title = {A novel inducible von Willebrand Factor Cre recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo},
journal = {Vascular Pharmacology},
year = {2024},
doi = {10.1016/j.vph.2024.107369}
}
EUVIMED